In Vitro Production of Echioidinin, 7-O-Methywogonin from Callus Cultures of Andrographis lineata and Their Cytotoxicity on Cancer Cells

Andrographis lineata is an herbal medicinal plant used in traditional medicine as a substitute for Andrographis paniculata. Here, using mature leaf explants of A. lineata we demonstrate for the first time the callus induction established on MS medium containing 1.0 mg l(-1) IAA. Dried callus was subjected to solvent extraction with acetone. Further the acetone residue was separated by silica gel column chromatography, crystallized and characterized on the basis of nuclear magnetic resonance (proton and c13) and liquid chromatographic mass spectroscopy. This analysis revealed the occurrence of two known flavones namely, 7-O-methylwogonin (MW) and Echioidinin (ED). Furthermore, these compounds were tested for their cytotoxicity against leukemic cell line, CEM. We identify that ED and MW induced cytotoxicity in a time-and concentration-dependent manner. Further increase in the LDH release upon treatment with ED and MW further confirmed our cytotoxicity results against leukemic cell line. Strikingly, MW was more potent than ED when compared by trypan blue and MTT assays. Our results recapitulate the utility of callus cultures for the production of plant specific bioactive secondary metabolites instead of using wild plants. Together, our in vitro studies provide new insights of A. lineata callus cultures serving as a source for cancer chemotherapeutic agents.

Industry perceptions of barriers to commercialization of regenerative medicine products in the UK.

AIMS: Regenerative medicine is an emerging field with the potential to provide widespread improvement in healthcare and patient wellbeing via the delivery of therapies that can restore, regenerate or repair damaged tissue. As an industry, it could significantly contribute to economic growth if products are successfully commercialized. However, to date, relatively few products have reached the market owing to a variety of barriers, including a lack of funding and regulatory hurdles. The present study analyzes industry perceptions of the barriers to commercialization that currently impede the success of the regenerative medicine industry in the UK. MATERIALS & METHODS: The analysis is based on 20 interviews with leading industrialists in the field. RESULTS: The study revealed that scientific research in regenerative medicine is thriving in the UK. Unfortunately, lack of access to capital, regulatory hurdles, lack of clinical evidence leading to problems with reimbursement, as well as the culture of the NHS do not provide a good environment for the commercialization of regenerative medicine products. CONCLUSION: Policy interventions, including increased translational government funding, a change in NHS and NICE organization and policies, and regulatory clarity, would likely improve the general outcomes for the regenerative medicine industry in the UK.

Energia nuclear

v. 1. Legislação -- v. 2. Mensagens presidenciais e outros documentos (notas, ofícios, cópias autênticas de documentação oficial diversa): Acordo de cooperação para usos civis de energia atômica entre o governo dos Estados Unidos do Brasil e o governo dos Estados Unidos da América. Programa Conjunto de Cooperação para o Reconhecimento dos Recursos de Urânio no Brasil. Decisão do Conselho de Segurança Nacional quanto à Política Nacional de Energia Nuclear -- v. 3. Legislação: Projetos. Comissão Parlamentar de Inquérito para Proceder a Investigações sobre o Problema de Energia Atômica no Brasil.

Atuação da Anvisa na fiscalização do setor nuclear brasileiro

Consultoria Legislativa - Área XVI - Saúde Pública, Sanitarismo.

Relatório do grupo de trabalho fiscalização e segurança nuclear

Relatório sobre o setor nuclear no Brasil desenvolvido por meio de ações do grupo de trabalho criado pela Comissão de Meio Ambiente e Desenvolvimento Sustentável.

Two Nuclear Localization Signals in USP1 Mediate Nuclear Import of the USP1/UAF1 Complex

9 p. : il.

Analysis of fish diversion efficiency and survivorship in the fish return system at San Onofre Nuclear Generating Station

This study examined the efficiency of fish diversion and survivorship of diverted fishes in the San Onofre Nuclear Generating Station Fish Return System in 1984 and 1985. Generally, fishes were diverted back to the ocean with high frequency, particularly in 1984. Most species were diverted at rates of 80% or more. Over 90% of the most abundant species, Engraulis mordax, were diverted. The system worked particularly well for strong-swimming forms such as Paralobrax clothratus, Atherinopsis californiensis, and Xenistius californiensis, and did not appreciably divert weaker-swimming species such as Porichthys notatus, Heterostichus rostratus, and Syngnathus sp. Return rates of some species were not as high in 1985 as in 1984. Individuals of most tested species survived both transit through the fish return system and 96 hours in a holding net. Some species, such as E. mordox, X. californiensis, and Umbrina roncador, experienced tittle or no mortality. Survivorship of Seriphus politus was highly variable and no Anchoa delicatissima survived. (PDF file contains 22 pages.)

Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18

Background: Implantation and growth of metastatic cancer cells at distant organs is promoted by inflammation-dependent mechanisms. A hepatic melanoma metastasis model where a majority of metastases are generated via interleukin-18-dependent mechanisms was used to test whether anti-inflammatory properties of resveratrol can interfere with mechanisms of metastasis. Methods: Two experimental treatment schedules were used: 1) Mice received one daily oral dose of 1 mg/kg resveratrol after cancer cell injection and the metastasis number and volume were determined on day 12. 2) Mice received one daily oral dose of 1 mg/kg resveratrol along the 5 days prior to the injection of cancer cells and both interleukin-18 (IL-18) concentration in the hepatic blood and microvascular retention of luciferase-transfected B16M cells were determined on the 18(th) hour. In vitro, primary cultured hepatic sinusoidal endothelial cells were treated with B16M-conditioned medium to mimic their in vivo activation by tumor-derived factors and the effect of resveratrol on IL-18 secretion, on vascular cell adhesion molecule-1 (VCAM-1) expression and on tumor cell adhesion were studied. The effect of resveratrol on melanoma cell activation by IL-18 was also studied. Results: Resveratrol remarkably inhibited hepatic retention and metastatic growth of melanoma cells by 50% and 75%, respectively. The mechanism involved IL-18 blockade at three levels: First, resveratrol prevented IL-18 augmentation in the blood of melanoma cell-infiltrated livers. Second, resveratrol inhibited IL-18-dependent expression of VCAM-1 by tumor-activated hepatic sinusoidal endothelium, preventing melanoma cell adhesion to the microvasculature. Third, resveratrol inhibited adhesion-and proliferation-stimulating effects of IL-18 on metastatic melanoma cells through hydrogen peroxide-dependent nuclear factor-kappaB translocation blockade on these cells. Conclusions: These results demonstrate multiple sites for therapeutic intervention using resveratrol within the prometastatic microenvironment generated by tumor-induced hepatic IL-18, and suggest a remarkable effect of resveratrol in the prevention of inflammation-dependent melanoma metastasis in the liver.

Validación de la cuantificación de la concentración hepática de hierro mediante resonancia magnética nuclear de 1-Tesla

Introducción: La medición de la concentración de hierro hepática (CHH) por RM es una técnica no invasiva de gran utilidad en el diagnóstico de los pacientes con sospecha de sobrecarga férrica en hígado. Objetivo:Validar la eficacia de la RM 1 Tesla en la determinación de la (CHH) en pacientes con sospecha de sobrecarga férrica. Validar su capacidad para diagnosticar o descartar la presencia de una CHH sugestiva de hemocromatosis. Pacientes y métodos:Estudio observacional, transversal, con inclusión prospectiva de pacientes consecutivos. De 2002 a 2010 hemos obtenido la CHH estimada mediante RM 1 Tesla (método Gandon) y de RM 1,5 Tesla (método Alústiza), y mediante BH, en 56 pacientes consecutivos (58RM:35/23). Resultados:Grupo RM 1 Tesla: de acuerdo con CHH en BH, 15 pacientes clasificados como normales (<36µmol/g)-la RM valoró correctamente 7; sobreestimó 8-; 15 grupo hemosiderosis (36-80 µmol/g)-RM valoró correctamente 5, sobreestimó 10-; 5 grupo hemocromatosis (>80 µmol/g)-valoró correctamente las 5-. Existió una correlación entre la determinación de la CHH por BH y RM 1 Tesla con r=0.619. Existieron diferencias estadísticamente significativas (p<0.05) entre CHH media por biopsia (53.43/DE45.67/IC95%37.74 a 69.12) y por RM 1 Tesla (76.14/DE47.31/IC95% 60.46 a 92.97), con sobrevaloración por parte de la RM. Grupo RM 1,5 Tesla: de acuerdo con CHH en BH, normal en 14, hemosiderosis en 6 y hemocromatosis en 3. La RM valoró correctamente 6 y sobreestimó 8 en grupo normal; grupo hemosiderosis, 3 correctamente, 3 sobrevalorados; grupo hemocromatosis, valoró correctamente los 3. La correlación entre CHH por BH y RM 1,5 Tesla fue de r=0.815. La CHH media obtenida por BH (69,34/DE152.1/IC95% 3.57 a 135.1 ) y RM 1,5 Tesla (70.43/DE 57.63/IC95% 45.51 a 95.36) no demostraron diferencias significativas (p>0.05). Conclusiones: La determinación de CHH por RM 1 Tesla (método Gandon) es útil para diagnosticar o descartar hemocromatosis y para diagnosticar CHH normal. Existe una importante tendencia a la sobreestimación en pacientes sin y con sobrecarga férrica en la CHH obtenida por RM 1 Tesla. La determinación de CHH por RM 1,5 Tesla (método Alústiza) es superior a la de RM 1 Tesla, aunque también existe una tendencia a sobreestimar. La CHH media obtenida por BH o RM 1,5 Tesla no tuvieron diferencias significativas. En cambio si existieron entre BH y RM 1 Tesla.